I sent this off to Imugene this morning - let's see what they reply with !
"Dear Imugene Management,
WhilstI support last month's Question and Answer session with investors, I have somequestions I would like answered as a large investor of Imugene.
Firstly, after pushing back Data results from trials to the middleof 2025. That now seems to have been abandoned. Please answer investors such asmyself, requesting a reliable timeline for such data. A passage of yearlyquarters beyond this year is not reasonable nor professional. Whilst Imugenemanagement, cannot understand as to why its share price is so underperformedand abysmal for investors, such data holds the key to share pricerecovery.
Secondly, Capital will need to be raised shortly by Imugene. Canmanagement please identify as per what means this will be undertaken - namelyintended participants, and when it's likely to occur.
In the interests of improved relations and transparency withinvestors- Please do not reply with company fine print, comprising evasivereasonings with a sole purpose to avoid answering my queries. This has beenprevalent in all other inquiries, made previously.
Your earliest response would be appreciated."
-Lets see how we go !
-GO IMU!
Not Financial Advice - Opinion Only - DYOR!
(20min delay)